SCHEMBL25017483

SCHEMBL25017483

c1ccc(-c2nc(-c3cccc4sc5ccccc5c34)nc(-c3cccc4sc5c(-c6nc(-c7ccccc7)nc7c6sc6ccccc67)cccc5c34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 3/20 0.37
▸ ALOX5 P09917 1/20 0.34
▸ ATM Q13315 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TNKS O95271 2/20 0.33
▸ TNKS2 Q9H2K2 2/20 0.33
▸ HRH4 Q9H3N8 1/20 0.32
▸ TSHR P16473 2/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ PIK3CA P42336 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22329602 0.98 LIMK1 (0.38) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL22330131 0.95 LIMK1 (0.37) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL22329296 0.95 LIMK1 (0.37) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL25016302 0.94 ALOX5 (0.38) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL25018087 0.94 ALOX5 (0.38) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL22195475 0.94 LIMK1 (0.36) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL25016728 0.94 ALOX5 (0.38) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL25017766 0.94 LIMK1 (0.36) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL25017451 0.94 ALOX5 (0.41) LIMK1ALOX5ATMMEN1KMT2A
SCHEMBL25017010 0.93 MEN1 (0.39) LIMK1ALOX5ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 LIMK1 389/4885ALOX5 366/4885ATM 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback